Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma

Robert M. Sharkey, Habibe Karacay, Christine R. Johnson, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang and David M. Goldenberg
Journal of Nuclear Medicine March 2009, 50 (3) 444-453; DOI: https://doi.org/10.2967/jnumed.108.058602
Robert M. Sharkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Habibe Karacay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine R. Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Litwin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edmund A. Rossi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. McBride
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chien-Hsing Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Goldenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. 3 444-453
DOI 
https://doi.org/10.2967/jnumed.108.058602
PubMed 
19223402

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 28, 2008
  • Accepted for publication December 2, 2008
  • Published online March 2, 2009.

Article Versions

  • previous version (February 17, 2009 - 06:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Robert M. Sharkey 1 ,
  2. Habibe Karacay 1 ,
  3. Christine R. Johnson 1 ,
  4. Samuel Litwin 2 ,
  5. Edmund A. Rossi 3 ,
  6. William J. McBride 4 ,
  7. Chien-Hsing Chang 3 , 4 and
  8. David M. Goldenberg 1
  1. 1Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Belleville, New Jersey; 2Fox Chase Cancer Center, Philadelphia, Pennsylvania; 3IBC Pharmaceuticals, Inc., Morris Plains, New Jersey; and 4Immunomedics, Inc., Morris Plains, New Jersey
  1. For correspondence or reprints contact: Robert M. Sharkey, Garden State Cancer Center at the Center for Molecular Medicine and Immunology, 520 Belleville Ave., Belleville, NJ 07109. E-mail: rmsharkey{at}gscancer.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 42 Citations
  • 47 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Radioimmunotherapy of human tumours
    Steven M. Larson, Jorge A. Carrasquillo, Nai-Kong V. Cheung, Oliver W. Press
    Nature Reviews Cancer 2015 15 6
  • Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
    Martina Steiner, Dario Neri
    Clinical Cancer Research 2011 17 20
  • Cancer Radioimmunotherapy
    Robert M Sharkey, David M Goldenberg
    Immunotherapy 2011 3 3
  • Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
    Laetitia E. Lamberts, Simon P. Williams, Anton G.T. Terwisscha van Scheltinga, Marjolijn N. Lub-de Hooge, Carolien P. Schröder, Jourik A. Gietema, Adrienne H. Brouwers, Elisabeth G.E. de Vries
    Journal of Clinical Oncology 2015 33 13
  • Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy
    Robert M. Sharkey, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang, David M. Goldenberg
    Seminars in Nuclear Medicine 2010 40 3
  • Epratuzumab–SN-38: A New Antibody–Drug Conjugate for the Therapy of Hematologic Malignancies
    Robert M. Sharkey, Serengulam V. Govindan, Thomas M. Cardillo, David M. Goldenberg
    Molecular Cancer Therapeutics 2012 11 1
  • A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
    Robert M. Sharkey, Oliver W. Press, David M. Goldenberg
    Blood 2009 113 17
  • Combinatorial drug therapy in cancer - New insights
    Karanpreet Bhatia, Bhumika, Asmita Das
    Life Sciences 2020 258
  • Radioimmunotherapy for B-Cell Non-Hodgkin Lymphomas
    Michael Tomblyn
    Cancer Control 2012 19 3
  • Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
    Hidekazu Kawashima
    The Scientific World Journal 2014 2014

Article usage

Article usage: February 2009 to April 2025

AbstractFullPdf
Feb 20096014
Mar 20091195598
Apr 2009432639
May 2009301124
Jun 2009431616
Jul 200925128
Aug 200924911
Sep 2009201415
Oct 20093649
Nov 2009253028
Dec 2009801918
Jan 2010191715
Feb 2010322120
Mar 2010103754
Apr 201017178
May 2010163022
Jun 2010282513
Jul 2010131512
Aug 20101621914
Sep 2010801813
Oct 2010201413
Nov 201092418
Dec 2010131916
Jan 2011172423
Feb 2011121624
Mar 2011231023
Apr 2011121319
May 2011211321
Jun 201129612
Jul 201115411
Aug 2011211330
Sep 2011381223
Oct 2011391621
Nov 2011311012
Dec 201131616
Jan 2012211717
Feb 201224614
Mar 2012371419
Apr 2012411116
May 2012311225
Jun 201216910
Jul 2012251022
Aug 20122279
Sep 2012231113
Oct 201231515
Nov 20121978
Dec 201230109
Jan 2013291410
Feb 2013282515
Mar 2013231629
Apr 201321514
May 2013362818
Jun 20132678
Jul 20131244
Aug 20132492
Sep 2013822
Oct 20131595
Nov 20131887
Dec 20131867
Jan 20142028
Feb 20141756
Mar 201412818
Apr 201416215
May 20141418
Jun 201424712
Jul 201414612
Aug 2014261116
Sep 201415513
Oct 201418511
Nov 201431612
Dec 2014538
Jan 20151322
Feb 20151974
Mar 201512105
Apr 20151544
May 20151477
Jun 201512146
Jul 20151703
Aug 20151063
Sep 201527114
Oct 20159164
Nov 201517913
Dec 201527156
Jan 20163199
Feb 201615812
Mar 201611215
Apr 20162538
May 201625717
Jun 2016151013
Jul 2016191115
Aug 201613812
Sep 201612109
Oct 201613712
Nov 20169115
Dec 201611112
Jan 201716108
Feb 2017895
Mar 201714216
Apr 2017675
May 20177104
Jun 20171382
Jul 2017950
Aug 20171295
Sep 2017121510
Oct 201713613
Nov 201715185
Dec 201722103
Jan 20182139
Feb 20189112
Mar 20185114
Apr 20189180
May 201816203
Jun 201819201
Jul 201817125
Aug 20181474
Sep 201824162
Oct 201815212
Nov 201813285
Dec 2018112910
Jan 201916201
Feb 201920162
Mar 201924195
Apr 201921133
May 2019842
Jun 20191136
Jul 201914107
Aug 2019475
Sep 2019916
Oct 2019713
Nov 2019849
Dec 2019322
Jan 2020433
Feb 2020748
Mar 20208610
Apr 2020643
May 2020966
Jun 2020639
Jul 2020501
Aug 2020521
Sep 2020410
Oct 20201935
Nov 2020454
Dec 2020345
Jan 2021242
Feb 20213158
Mar 20211148
Apr 202101618
May 20214104
Jun 20210102
Jul 20211147
Aug 202121914
Sep 2021163
Oct 20211416
Nov 20211419
Dec 202111511
Jan 20223114
Feb 2022164
Mar 20220116
Apr 20222107
May 20222612
Jun 20221912
Jul 20221136
Aug 20223126
Sep 2022086
Oct 2022297
Nov 20222106
Dec 2022271
Jan 202333217
Feb 20232167
Mar 202311912
Apr 202311911
May 2023286
Jun 20230114
Jul 20232610
Aug 2023277
Sep 20232106
Oct 20230107
Nov 2023267
Dec 20233182
Jan 20242164
Feb 20241136
Mar 20240542
Apr 2024221811
May 202401512
Jun 20241185
Jul 202431612
Aug 202435614
Sep 202432218
Oct 202472415
Nov 20240134
Dec 202403213
Jan 202511826
Feb 202525710
Mar 2025419917
Apr 202575413
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (3)
Journal of Nuclear Medicine
Vol. 50, Issue 3
March 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
Robert M. Sharkey, Habibe Karacay, Christine R. Johnson, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang, David M. Goldenberg
Journal of Nuclear Medicine Mar 2009, 50 (3) 444-453; DOI: 10.2967/jnumed.108.058602

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
Robert M. Sharkey, Habibe Karacay, Christine R. Johnson, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang, David M. Goldenberg
Journal of Nuclear Medicine Mar 2009, 50 (3) 444-453; DOI: 10.2967/jnumed.108.058602
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
  • A New Tri-Fab Bispecific Antibody for Pretargeting Trop-2-Expressing Epithelial Cancers
  • Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody-Drug Conjugate
  • Effect of Small-Molecule-Binding Affinity on Tumor Uptake In Vivo: A Systematic Study Using a Pretargeted Bispecific Antibody
  • Epratuzumab-SN-38: A New Antibody-Drug Conjugate for the Therapy of Hematologic Malignancies
  • Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
  • Combination Radioimmunotherapy and Chemoimmunotherapy Involving Different or the Same Targets Improves Therapy of Human Pancreatic Carcinoma Xenograft Models
  • A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire